What is asthma?
What are the 3 factors that contribute to airway narrowing?
A chronic inflammatory disorder of lung airways, characterised by airway hyperresponsiveness leading to bronchospasm and reversible airway obstruction.
-Reversible airway narrowing
What are the main two types of asthma?
What are the RF for asthma?
What is the typical presentation of asthma?
-In children –> cough wheezing, may describe tight chest as tummy ache. Ask about premature birth, low birth weight, previous bronchiolitis or croup
What are the 1st line and gold standard investigations for asthma?
GOLD STANDARD –> exhaled nitric oxide. Fraction of exhaled nitric oxide >40ppb +ve for asthma. Leverl in breath, produced to fight inflamm –> muscle relaxant. Normal <25 adults, <20 children.
1st line –> Spirometry w reversibility. FEV1/FVC ratio <70% adults <85% children. Reversibility testing –> asthma suggested by larger >400ml response to bronchodilators or prednisolone. FEV1 increase 12% and increase 200ml volume.
Alternative when spirometry not available –> peak flow –> PEFR reduced in asthma. Peak flow meter and diary 2-4 weeks aid diagnosis. 20% diurnal variation >3 days a week for two weeks –> typical asthma. Compare to expected values e.g age, gender, height.
-Children <5 can’t perform spirometry –> clinical diagnosis, trial treatment e.g low dose ICS,
What is the management for asthma in adults?
What are the features that mean asthma is not being controlled?
Aim –> No daytime symptoms, no night time waking, no need for resuce medicaiton, no limitations ADL, no attacks.
Step wise –> Move up and down as needed
1 –> SABA as required for symptom relief. More than OD or night time symptoms –> step 2. Most patients start step 2.
2 –> Add low dose ICS. Beclomethasone, budesomide.
3 –> Add LTRA. Montelukast. Check patients adherence and inhaler technique.
4 –> Add LABA. Salmeterol. W or w/o LTRA depends whether effective.
5 –> Low dose ICS w LABA in MART regimen. Symbicort.
6 –> Increase ICS to moderate.
7 –> Increase ICS to high. Refer to specialist.
MART –> Maintenance and reliever therapy. Combined ICS and LABA in one inhaler.
-Severe eosinophilic –> biologic therapies. Anti IgE –> omalizumab –> removes IgE allergy Ab. £30,000 per year.
What is the management for asthma in over 5’s - 16s?
1 --> SABA 2 --> Low dose ICS and LTRA 3 --> Stop LTRA, add LABA 4 --> MART 5 --> Moderate dose ICS 6 --> High dose ICS specialist
What is the management for asthma in under 5’s?
1 --> SABA 2 --> Low dose ICS 3 --> Moderate dose ICS 4 --> Add LTRA 5 --> Stop LTRA, specialist
What is a severe asthma attack and how should it be managed?
Severe Any one of
What are the differences in presentation COPD v asthma?
What is COPD?
Bronchitis
Emphysema
-Destruction of lung parenchyma w dilation f alveolar airspaces w loss of elastic recoil and air trapping.
-Patients w COPD divide into those w predominant breathlessness (emphysema) or predominant exacerbations (chronic bronchitis).
What are the risk factors for COPD?
What is the typical presentation of COPD?
What is the presentation of an acute excerbation?
-Acute exacerbation –> worsening previously stable COPD, beyond day to day variation. Mya be due to viral or bacterial infection. Increase SOB, sputum volume and purulence.
What are the 1st line and gold standard investigations for COPD?
1st line and GOLD standard –> spirometry w reversibility testing.
What is ACCOS?
What is the staging for COPD?
Stage by FEV1
What is the MRC dyspnoea scale?
Measures impact of SOB on patient
1 –> SOB on exertion
2 –> SOB up hills or walking quickly
3 –> Walks slower or stop on flat as SOB
4 –> Exercise tolerance 100-200 yards on flat
5 –> Housebound, SOB on minor tasks
What is the medical management for COPD?
Step 1 –> breathless and exercise limitation –> SABA PRN. Continue at all steps.
Step 2 –> Still symptomatic, combination inhaler
Step 3 –> Ongoing excaberations (2 or more in 6 months) or admission to hospital.
-Triple therapy –> ICS and LABA and LAMA.
Step 4
-Still symptomatic –> consider theophylline
What are the other interventions in COPD?
How should exacerbations of COPD be treated?
What should be done when there is no improvement in symptoms?
No improvement in symptoms on first choice for 2-3 days
If the person is at higher risk of treatment failure e.g frequent antibiotic use, previous or current sputum culture with resistant bacteria or high risk of developing complications)
-Consider prescribing co-amoxiclav 500/125 mg TDS 5 days
What is sleep apnoea?
What are the RF?
What is the typical history and presentation of sleep apneoa?
What are the investigations for sleep apnoea?
What is the diagnostic test?
What is the management for sleep apnoea?